Financials
- Market Capitalization 2.46 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.32
市销率
-2 874.39
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1856 | PGEN Precigen, Inc. - Common Stock | 6.93 USD | -0.29% | -4.94% | +11.24% | +54.34% | 2.48 B USD | ||
| 1857 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.70 USD | -1.22% | -0.92% | +7.78% | +15.89% | 2.48 B USD | ||
| 1868 | NKTR Nektar Therapeutics - Common Stock | 71.38 USD | -1.57% | -4.80% | +0.93% | -2.58% | 2.44 B USD | ||
| 1887 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.60 USD | -1.13% | -9.24% | -9.44% | +132.17% | 2.37 B USD |